MedPath

Fluorouracil

Generic Name
Fluorouracil
Brand Names
Actikerall, Carac, Efudex, Fluoroplex, Tolak
Drug Type
Small Molecule
Chemical Formula
C4H3FN2O2
CAS Number
51-21-8
Unique Ingredient Identifier
U3P01618RT

Overview

A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid.

Background

A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid.

Indication

For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, esophageal, gastric, rectum, breast, biliary tract, stomach, head and neck, cervical, pancreas, renal cell, and carcinoid.

Associated Conditions

  • Actinic Keratosis (AK)
  • Breast Cancer
  • Colon Cancer
  • Gastric Cancer
  • Pancreatic Cancer
  • Rectal Cancer
  • Superficial Basal Cell Carcinoma
  • Verruca (Warts)
  • Hyperkeratotic actinic keratosis

FDA Approved Products

FLUOROURACIL
Manufacturer:Rebel Distributors Corp
Route:TOPICAL
Strength:50 mg in 1 g
Approved: 2009/09/22
NDC:21695-829
Carac
Manufacturer:Bausch Health US, LLC
Route:TOPICAL
Strength:5 mg in 1 g
Approved: 2021/05/17
NDC:0187-5200
FLUOROURACIL
Manufacturer:Physicians Total Care, Inc.
Route:TOPICAL
Strength:50 mg in 1 g
Approved: 2011/09/06
NDC:54868-6293
Fluorouracil
Manufacturer:A-S Medication Solutions
Route:TOPICAL
Strength:50 mg in 1 g
Approved: 2021/04/30
NDC:50090-4264
Fluorouracil
Manufacturer:Accord Healthcare, Inc.
Route:INTRAVENOUS
Strength:50 mg in 1 mL
Approved: 2017/02/23
NDC:16729-276

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath